Showing results (781-790 of 798) with videos related to
Sort By:
Pageof 80
European Urology Focus|January 9, 2021
Initial Experience and Evaluation of a Nomogram for Outcome Prediction in Management of Medium-sized (1-2 cm) Kidney StonesSalvatore Micali, Maria Chiara Sighinolfi, Andrea Iseppi, et al.Science Translational Medicine|February 21, 2014
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemiaMarco L Davila, Isabelle Riviere, Xiuyan Wang, et al.Human Molecular Genetics|September 5, 2001
The mutational spectrum of human malignant autosomal recessive osteopetrosisC Sobacchi, A Frattini, P Orchard, et al.Blood|October 7, 2020
Ivosidenib or enasidenib combined with intensive chemotherapy in patients with newly diagnosed AML: a phase 1 studyEytan M Stein, Courtney D DiNardo, Amir T Fathi, et al.Brain : a Journal of Neurology|November 21, 2024
Lewy pathology formation in patient-derived GBA1 Parkinson's disease midbrain organoidsEmanuele Frattini, Gaia Faustini, Gianluca Lopez, et al.Leukemia|July 25, 2018
Clonal diversity predicts adverse outcome in chronic lymphocytic leukemiaAlexander C Leeksma, Justin Taylor, Bian Wu, et al.Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|May 7, 2013
Moderate alcohol use and health: a consensus documentA Poli, F Marangoni, A Avogaro, et al.Cell Host & Microbe|March 12, 2026
Intratumoral microbiota and host genotype cooperatively shape neutrophil cytotoxic functions in colorectal cancerElisa Sorrenti, Valeria Governa, Davide Bressan, et al.The Lancet. Oncology|July 13, 2010
Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysisWendy De Roock, Bart Claes, David Bernasconi, et al.Nature Biotechnology|December 18, 2018
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identificationBrendan Bulik-Sullivan, Jennifer Busby, Christine D Palmer, et al.Pageof 80